BAMF Health today announced the launch of BAMF RadioNexus, a new nationwide clinical trials platform focused on rapidly advancing radiopharmaceutical research, development, and commercialization. As innovation in the field accelerates, there’s a growing need for highly qualified sites equipped with the specialized infrastructure, expertise, and support required to run these complex trials. BAMF RadioNexus brings BAMF’s operational and scientific expertise to partner sites across the U.S., enhancing health systems’ ability to quickly initiate cutting-edge trials in cancer, neurodegenerative disease, and other high-need areas. It’s a scalable solution for expanding access to advanced clinical trials, in turn accelerating clinical development.
“RadioNexus combines BAMF Health’s radiopharmaceutical clinical trials leadership with the oncology and patient care strengths of our exceptional partners,” said Dan Rogers, Director of Clinical Trials Platform. “Together, we’re building the research infrastructure and growing the expertise needed to accelerate the development of personalized care for patients who need it most. Cancer won’t wait, and neither will we.”
A Smarter Approach to Complex Trials
Radiopharmaceutical trials are uniquely challenging, encompassing protocol design, regulatory navigation, and patient access. BAMF RadioNexus is built to meet those challenges head-on by delivering sponsor-ready trial infrastructure at trusted, high-performing care centers.
For pharmaceutical sponsors, BAMF RadioNexus offers a faster and more consistent path to trial execution. The platform enables accelerated study startup and site activation, while offering access to a growing network of diverse patient populations. With centralized oversight and standardized processes, BAMF RadioNexus delivers greater consistency in trial operations and data capture. Sponsors also benefit from working with an experienced, embedded partner who understands and navigates the regulatory complexity unique to radiopharmaceutical development.
Health systems that join the BAMF RadioNexus network gain priority access to sponsor-driven radiopharmaceutical trials, backed by centralized administrative and regulatory support. Each partner site receives tailored training and implementation support, guided by BAMF Health’s best practices in radiopharmaceutical research. The platform empowers sites to build internal capabilities and infrastructure, while offering patients the opportunity to participate in cutting-edge, high-impact trials they might not otherwise have access to.
“RadioNexus helps close the gap between scientific innovation and real-world access,” said BAMF Health VP of Radiopharmacy, Matt DeLong. “Our expertise in manufacturing and sourcing the highest quality radiopharmaceuticals will dramatically increase accessibility for our partners and their patients.”
Expansion of RadioNexus
BAMF is in the process of enrolling additional health systems, including academic health systems, into the RadioNexus platform to further expand access and accelerate research.
“RadioNexus is one example of BAMF Health’s broader vision to establish value-added partnerships across the country,” said BAMF Health VP of Real Estate, Design, and Partnerships, Laurie Placinski. “Our vision is to build a nationwide network of leading health systems working together to accelerate clinical development in radiopharmaceuticals and beyond.”
By expanding the RadioNexus platform, BAMF will open the door to more trials, reach a wider range of patients, and accelerate the advancement of personalized care faster than ever before.
About BAMF RadioNexus
Backed by BAMF Health’s deep clinical expertise, BAMF RadioNexus connects leading health systems, academic medical centers, and independent practices to run smarter, faster, and more scalable clinical trials in molecular imaging and therapy. By delivering radiopharmaceutical-trial-specific best practices, operational support, and site enablement tools, BAMF RadioNexus drives faster activation and high-quality trial execution. Our mission is to ensure people across the country have access to advanced, high-quality, life-saving options for cancer and other conditions. To learn more about BAMF RadioNexus, visit: www.bamfhealth.com/radionexus
